ORPATHYS Trademark

Trademark Overview

On Thursday, November 7, 2019, a trademark application was filed for ORPATHYS with the United States Patent and Trademark Office. The USPTO has given the ORPATHYS trademark a serial number of 88683714. The federal status of this trademark filing is REGISTERED as of Tuesday, December 21, 2021. This trademark is owned by AstraZeneca AB. The ORPATHYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
orpathys

General Information

Serial Number88683714
Word MarkORPATHYS
Filing DateThursday, November 7, 2019
Status700 - REGISTERED
Status DateTuesday, December 21, 2021
Registration Number6592702
Registration DateTuesday, December 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, December 21, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, November 18, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 8, 2021NOTICE OF ALLOWANCE CANCELLED
Thursday, November 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 8, 2021TEAS DELETE 1(B) BASIS RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 18, 2021EXTENSION 2 GRANTED
Tuesday, May 18, 2021EXTENSION 2 FILED
Tuesday, May 18, 2021TEAS EXTENSION RECEIVED
Friday, December 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 2, 2020EXTENSION 1 GRANTED
Wednesday, December 2, 2020EXTENSION 1 FILED
Wednesday, December 2, 2020TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020ASSIGNED TO LIE
Wednesday, February 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 7, 2020ASSIGNED TO EXAMINER
Thursday, November 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

orpathys disorders diseases pharmaceutical anemia substances preparations nervous system inflammation infection